Whitney G S, Starling G C, Bowen M A, Modrell B, Siadak A W, Aruffo A
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.
J Biol Chem. 1995 Aug 4;270(31):18187-90. doi: 10.1074/jbc.270.31.18187.
Binding studies with a CD6 immunoglobulin fusion protein (CD6 Rg) resulted in the identification and cloning of a CD6 ligand. This ligand was found to be a member of the immunoglobulin supergene family and was named ALCAM (activated leukocyte cell adhesion molecule). Cell adhesion assays showed that CD6-ALCAM interactions mediate thymocyte-thymic epithelium cell binding. ALCAM is also expressed by activated leukocytes and neurons and may be involved in interactions between T cells and activated leukocytes and between cells of the immune and nervous systems, respectively. Herein we describe the preparation of domain-specific murine CD6 Rg fusion proteins and show that the membrane-proximal SRCR (scavenger receptor cysteine-rich) domain of CD6 contains the ALCAM binding site. We also show that mAbs which bind to this domain preferentially block CD6-ALCAM binding. These results demonstrate that the membrane-proximal SRCR domain of CD6 is necessary for CD6 binding to ALCAM and provide the first direct evidence for the interaction of an SRCR domain with a ligand.
用CD6免疫球蛋白融合蛋白(CD6 Rg)进行的结合研究导致了一种CD6配体的鉴定和克隆。发现该配体是免疫球蛋白超基因家族的成员,并被命名为ALCAM(活化白细胞细胞粘附分子)。细胞粘附试验表明,CD6-ALCAM相互作用介导胸腺细胞与胸腺上皮细胞的结合。ALCAM也在活化的白细胞和神经元中表达,可能分别参与T细胞与活化白细胞之间以及免疫和神经系统细胞之间的相互作用。在此,我们描述了结构域特异性小鼠CD6 Rg融合蛋白的制备,并表明CD6的膜近端富含半胱氨酸的清道夫受体(SRCR)结构域包含ALCAM结合位点。我们还表明,结合该结构域的单克隆抗体优先阻断CD6-ALCAM结合。这些结果证明,CD6的膜近端SRCR结构域对于CD6与ALCAM的结合是必需的,并为SRCR结构域与配体的相互作用提供了首个直接证据。